Premium
P4‐088: Central and Peripheral Pharmacokinetic and Pharmacodynamic Effects of the β‐site APP Cleavage Enzyme (BACE1) Inhibitor LY2811376 In Humans
Author(s) -
Martenyi Ferenc,
Lowe Stephen,
Dean Robert A.,
Monk Scott A.,
Gonzales Celedon R.,
Friedrich Stuart,
May Patrick C.,
Audia James E.,
Citron Martin,
LaBell Elizabeth S.,
Moran Samira,
Yen Mark,
Jhee Stanford,
Kam Jeanelle,
Ereshefsky Larry
Publication year - 2010
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2010.08.148
Subject(s) - pharmacokinetics , pharmacodynamics , pharmacology , biomarker , placebo , dosing , medicine , dose–response relationship , toxicity , area under the curve , chemistry , pathology , biochemistry , alternative medicine